As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...
As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...
Current quality measures usually assess performance against a standard of care for a typical patient rather than the specific patient receiving care, much like value frameworks assess value for a typical patient....
Current quality measures usually assess performance against a standard of care for a typical patient rather than the specific patient receiving care, much like value frameworks assess value for a typical patient....
Health care treatments are becoming increasingly tailored to individual patients in terms of patient preferences and individual clinical factors. However, these tailored treatments often have a high price tag....
Health care treatments are becoming increasingly tailored to individual patients in terms of patient preferences and individual clinical factors. However, these tailored treatments often have a high price tag....
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
Matthew Pakizegee, PharmD, MS; Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
The Centers for Medicare & Medicaid Services (CMS) released an advanced notice of proposed rulemaking on October 25, 2018, seeking to test whether using a combination of 3 approaches—an international drug...
The Centers for Medicare & Medicaid Services (CMS) released an advanced notice of proposed rulemaking on October 25, 2018, seeking to test whether using a combination of 3 approaches—an international drug...
Abstract: When launched in 2016, the Oncology Care Model (OCM) represented one of the most advanced efforts yet to migrate health care delivery from fee-for-service to fee-for-value. Practices representing nearly...
Abstract: When launched in 2016, the Oncology Care Model (OCM) represented one of the most advanced efforts yet to migrate health care delivery from fee-for-service to fee-for-value. Practices representing nearly...
Abstract: As a value-based payment model, bundled payments represent a key component of the ongoing nationwide shift toward value-based care. The Centers for Medicare & Medicaid Services (CMS) has led the...
Abstract: As a value-based payment model, bundled payments represent a key component of the ongoing nationwide shift toward value-based care. The Centers for Medicare & Medicaid Services (CMS) has led the...
Founded in 2016, the Clinical Pathways Forum is a community of pathways professionals now totaling over 12 institutions from across the United States and Canada who are utilizing clinical pathways in their practices...
Founded in 2016, the Clinical Pathways Forum is a community of pathways professionals now totaling over 12 institutions from across the United States and Canada who are utilizing clinical pathways in their practices...
The 2018 San Antonio Breast Cancer Symposium (SABCS) brought together more than 7000 physicians and researchers from around the globe from December 4 through 8 in San Antonio, Texas.
SABCS began in 1977 as a...
The 2018 San Antonio Breast Cancer Symposium (SABCS) brought together more than 7000 physicians and researchers from around the globe from December 4 through 8 in San Antonio, Texas.
SABCS began in 1977 as a...
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The updated 2024 NCCN Guidelines® recommend broad genomic testing and the need for multidisciplinary care to accurately diagnose and treat non-small cell lung cancer. View this special report to learn more.
The updated 2024 NCCN Guidelines® recommend broad genomic testing and the need for multidisciplinary care to accurately diagnose and treat non-small cell lung cancer. View this special report to learn more.
Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.
Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.
This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.
This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.
In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...
In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...
This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...
This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...
In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.
In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.
Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.
Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.
In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.
In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...